Contribution of oncoproteomics to cancer biomarker discovery

Overview of attention for article published in Molecular Cancer, April 2007

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news: 1 news outlet

patent: 2 patents

Citations

dimensions_citation: 214 Dimensions

Readers on

mendeley: 230 Mendeley
citeulike: 4 CiteULike
connotea: 4 Connotea

Summary News Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

PLECTIN-TARGETED LIPOSOMES/PARP INHIBITOR IN THE TREATMENT OF CANCER

Application WO-2019168921-A1

World Intellectual Property Organisation (WIPO)

Predicting tumor response to anti-ERBB3 antibodies

Grant US-9828635-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.